Framework for IV immunoglobulins and prothrombin complex

This is an open procedure framework agreement for the supply of IV immunoglobulins and prothrombin complex concentrate to a network of 7 hospitals in Belgium. The framework has a fixed 2-year term, renewable twice for 1 year each (max 4 years). The tender is divided into 3 lots: Lot 1 (IV Immunoglobulins 90% share), Lot 2 (IV Immunoglobulins 10% share), and Lot 3 (Prothrombin complex concentrate). The total framework maximum value is €31,342,500. Submission deadline is 10 August 2026. Only Dutch language is accepted. The tender requires specific financial, GDPR, and GMP/GDP compliance documents.